MESA, ARIZONA / ACCESS Newswire / September 25, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced that its AI Facial Health Risk Estimator now includes early detection and monitoring of glaucoma and cataracts, two leading causes of vision loss globally.
Using high-resolution facial and ocular image analysis, the platform detects:
Corneal opacity and lens clouding for cataracts
Early optic nerve changes and other glaucoma biomarkers
This integration allows patients and clinicians to monitor eye health alongside systemic and dermatological metrics, creating a comprehensive preventive care solution.
"Our AI platform is holistic," said Marshall Perkins, CEO of MDCE. "Detecting vision-threatening conditions early preserves sight and advances global standards in preventive medicine."
Company Websites: www.medicalcaretechnologies.com | www.mdcestock.com
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK: MDCE) leverages AI for early disease detection across dermatology, neurology, ocular, and systemic health domains.
Safe Harbor Statement:
This release contains forward-looking statements; actual results may differ due to risks and uncertainties.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medical-care-technologies-inc.-expands-ai-platform-to-detect-glaucoma-1075303
